Key facts
- This page summarizes Daniel Patrick O'Day's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2022, 18:15.
Daniel Patrick O'Day - 01 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- Chairman & CEO, Director
- Issuer ticker
- GILD
- Reported as of
- 01 Mar 2022
- Net transaction value
- -$1,400,744
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2022, 18:15:12 UTC
- Prior SEC filing
- 28 Jan 2022
- Next SEC filing
- 14 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Daniel O'Day
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel Patrick O'Day filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 03 Mar 2022.
Change
- Previous filing in this sequence was filed on 28 Jan 2022.
- Current net transaction value: -$1,400,744.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +11,362
- Change %
- +5.5%
- Price
- Shares after
- 216,716
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +42,922
- Change %
- +20%
- Price
- Shares after
- 259,638
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- $1,400,744
- Shares
- -23,245
- Change %
- -9%
- Price
- $60.26
- Shares after
- 236,393
- Date
- 01 Mar 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -11,362
- Change %
- -7.5%
- Price
- Shares after
- 139,494
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,362
- Exercise price
- Footnotes
- F1, F2
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -42,922
- Change %
- -31%
- Price
- Shares after
- 96,572
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42,922
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
Footnote F3
The restricted stock units have a three year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested.